Showing results (181-190 of 536) with videos related to
Sort By:
Pageof 54
Lymphology|April 19, 2000
Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with non-smokersH Sinzinger, J Kaliman, A OguoghoFolia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
The platelet rebound phenomenon during PGI2-infusion occurs at the receptor levelG Steurer, P Fitscha, H SinzingerWiener Klinische Wochenschrift|January 1, 1991
[Effect of bezafibrate in isolated hypercholesterolemia and mixed hyperlipidemia on infarct risk (Stepwise Program for Individual Risk Identification and Therapy): an open multicenter study]H Sinzinger, I Virgolini, P KudlacekWiener Klinische Wochenschrift|January 1, 1993
Coffee, lipoproteins and cardiovascular diseaseC Pirich, J O'Grady, H SinzingerLymphology|February 9, 1999
Levels of eicosanoids (6-oxo-PGF1 alpha and 8-epi-PGF2 alpha) in human and porcine lymphatics and lymphA Oguogho, J Kaliman, H SinzingerKlinische Wochenschrift|September 1, 1988
[Prevalence of plasma factor deficiency in the Vienna population. Results of a screening study of 1,300 adults]H Sinzinger, J Flores, F RauschaThe Journal of International Medical Research|January 1, 1988
Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamoleH Sinzinger, J O'Grady, P FitschaEuropean Journal of Nuclear Medicine|September 2, 1998
Adsorption of technetium-99m tetrofosmin and technetium-99m furifosmin on plastic syringesR Bartosch, S Granegger, H SinzingerLymphology|October 6, 1997
Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphaticsH Sinzinger, A Oguogho, J KalimanProstaglandins|June 1, 1987
Prostaglandin I2 during radiolabelling improves recovery, but does not change platelet half-life and platelet uptake over active human lesion sitesH Sinzinger, P Fitscha, J KalimanPageof 54